Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1186/s12890-020-01343-z

http://scihub22266oqcxt.onion/10.1186/s12890-020-01343-z
suck pdf from google scholar
33198751!7668012!33198751
unlimited free pdf from europmc33198751    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33198751      BMC+Pulm+Med 2020 ; 20 (1): 301
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome #MMPMID33198751
  • Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
  • BMC Pulm Med 2020[Nov]; 20 (1): 301 PMID33198751show ga
  • BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly reached pandemic proportions. Given that the main target of SARS-CoV-2 are lungs leading to severe pneumonia with hyperactivation of the inflammatory cascade, we conducted a prospective study to assess alveolar inflammatory status in patients with moderate to severe COVID-19. METHODS: Diagnostic bronchoalveolar lavage (BAL) was performed in 33 adult patients with SARS-CoV-2 infection by real-time PCR on nasopharyngeal swab admitted to the Intensive care unit (ICU) (n = 28) and to the Intermediate Medicine Ward (IMW) (n = 5). We analyze the differential cell count, ultrastructure of cells and Interleukin (IL)6, 8 and 10 levels. RESULTS: ICU patients showed a marked increase in neutrophils (1.24 x 10(5) ml(- 1), 0.85-2.07), lower lymphocyte (0.97 x 10(5) ml(- 1), 0.024-0.34) and macrophages fractions (0.43 x 10(5) ml(- 1), 0.34-1.62) compared to IMW patients (0.095 x 10(5) ml(- 1), 0.05-0.73; 0.47 x 10(5) ml(- 1), 0.28-1.01 and 2.14 x 10(5) ml(- 1), 1.17-3.01, respectively) (p < 0.01). Study of ICU patients BAL by electron transmission microscopy showed viral particles inside mononuclear cells confirmed by immunostaining with anti-viral capsid and spike antibodies. IL6 and IL8 were significantly higher in ICU patients than in IMW (IL6 p < 0.01, IL8 p < 0.0001), and also in patients who did not survive (IL6 p < 0.05, IL8 p = 0.05 vs. survivors). IL10 did not show a significant variation between groups. Dividing patients by treatment received, lower BAL concentrations of IL6 were found in patients treated with steroids as compared to those treated with tocilizumab (p < 0.1) or antivirals (p < 0.05). CONCLUSIONS: Alveolitis, associated with COVID-19, is mainly sustained by innate effectors which showed features of extensive activation. The burden of pro-inflammatory cytokines IL6 and IL8 in the broncho-alveolar environment is associated with clinical outcome.
  • |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH]
  • |Adrenal Cortex Hormones/therapeutic use[MESH]
  • |Aged[MESH]
  • |Alanine/analogs & derivatives/therapeutic use[MESH]
  • |Antibodies, Monoclonal, Humanized/therapeutic use[MESH]
  • |Antiviral Agents/therapeutic use[MESH]
  • |Betacoronavirus[MESH]
  • |Bronchoalveolar Lavage[MESH]
  • |Bronchoalveolar Lavage Fluid/cytology/*immunology/virology[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |Coronavirus Infections/drug therapy/*immunology/therapy[MESH]
  • |Drug Combinations[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Hydroxychloroquine/therapeutic use[MESH]
  • |Inflammation/*immunology[MESH]
  • |Intensive Care Units[MESH]
  • |Interleukin-10/immunology[MESH]
  • |Interleukin-6/*immunology[MESH]
  • |Interleukin-8/*immunology[MESH]
  • |Italy[MESH]
  • |Leukocytes, Mononuclear/virology[MESH]
  • |Leukocytes/*immunology[MESH]
  • |Lopinavir/therapeutic use[MESH]
  • |Lung/cytology/*immunology/virology[MESH]
  • |Lymphocytes/immunology[MESH]
  • |Macrophages, Alveolar/*immunology[MESH]
  • |Male[MESH]
  • |Microscopy, Electron, Transmission[MESH]
  • |Middle Aged[MESH]
  • |Neutrophils/immunology[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*immunology/therapy[MESH]
  • |Prognosis[MESH]
  • |Prospective Studies[MESH]
  • |Respiration, Artificial/methods[MESH]
  • |Ritonavir/therapeutic use[MESH]
  • |SARS-CoV-2[MESH]
  • |Spike Glycoprotein, Coronavirus/metabolism[MESH]
  • |Survival Rate[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box